AB-Gen:抗体图书馆设计与生成预训练变压器和深度增强学习
Xiaopeng Xu1, Tiantian Xu2, Juexiao Zhou1
1Computational Bioscience Research Center (CBRC), King Abdullah University of Science and Technology, Thuwal 23955-6900, Saudi Arabia.
Genomics, proteomics & bioinformatics
|June 26, 2023
概括
一种新的强化学习 (RL) 方法,AB-Gen,通过设计新的抗体序列来加速抗体发现. 这种人工智能驱动的方法同时优化了多种特性,提高了临床前抗体开发的成功率.
科学领域:
- 生物技术是生物技术.
- 人工智能在药物发现中的作用
- 蛋白质工程是指蛋白质的工程.
背景情况:
- 抗体开发需要优化临床候选的多种性质.
- 目前的多物业优化方法由于实验吞吐量低和物业之间的权衡而面临瓶.
研究的目的:
- 开发一种人工智能驱动的方法,用于高效的抗体库设计.
- 为了克服抗体发现中传统的提出-然后-过方法的局限性.
主要方法:
- 开发了AB-Gen,一种强化学习 (RL) 方法,使用生成预训练变压器 (GPT) 作为政策网络.
- 训练RL剂学习抗体序列空间,特别是重链互补性确定区域3 (CDRH3).
- 应用AB-Gen来设计针对人类表皮生长因子受体-2 (HER2) 的新型CDRH3序列,具有多属性约束.
主要成果:
- AB-Gen成功地学习了抗体序列特性,并生成了具有类似分布的序列.
- 产生了新的CDRH3序列,满足HER2向的多个属性约束.
- 通过所有过器识别了509个序列,通过分子动力学模拟验证了三个保存的残留物.
结论:
- 与传统方法相比,AB-Gen方法在设计新型抗体序列方面取得了更高的成功率.
- AB-Gen有效地掌握了复杂的优化任务,显示了实际抗体设计的潜力.
- 这种人工智能驱动的方法可以显著增强和加速抗体发现和开发过程.
更多相关视频
12:31Construction of Synthetic Phage Displayed Fab Library with Tailored Diversity
Published on: May 1, 2018
13.8K
10:17Creating Highly Specific Chemically Induced Protein Dimerization Systems by Stepwise Phage Selection of a Combinatorial Single-Domain Antibody Library
Published on: January 14, 2020
7.8K
相关概念视频
01:31Hybridoma Technology
15.0K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
15.0K
01:25Antibody Structure and Classes
985
Antibodies, also known as immunoglobulins, are produced by B cells in response to foreign substances, such as bacteria and viruses. These proteins are critical for recognizing and neutralizing these substances, protecting the body from potential harm.
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
985